Search by Drug Name or NDC

NDC 69238-1656-05 Sucralfate 1 g/1 Details

Sucralfate 1 g/1

Sucralfate is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Amneal Pharmaceuticals NY LLC. The primary component is SUCRALFATE.

MedlinePlus Drug Summary

Sucralfate is used to treat and prevent the return of duodenal ulcers (ulcers located in first part of the small intestine). Treatment with other medications, such as antibiotics, may also be necessary to treat and prevent the return of ulcers caused by a certain type of bacteria (H. pylori) Sucralfate is in a class of medications called protectants. It sticks to damaged ulcer tissue and protects against acid and enzymes so healing can occur.

Related Packages: 69238-1656-05
Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Sucralfate

Product Information

NDC	69238-1656
Product ID	69238-1656_507ba68d-7593-4545-bbe1-dc9463c1a893
Associated GPIs	49300010000305
GCN Sequence Number	002766
GCN Sequence Number Description	sucralfate TABLET 1 G ORAL
HIC3	D4E
HIC3 Description	ANTI-ULCER PREPARATIONS
GCN	08200
HICL Sequence Number	001186
HICL Sequence Number Description	SUCRALFATE
Brand/Generic	Generic
Proprietary Name	Sucralfate
Proprietary Name Suffix	n/a
Non-Proprietary Name	Sucralfate
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET
Route	ORAL
Active Ingredient Strength	1
Active Ingredient Units	g/1
Substance Name	SUCRALFATE
Labeler Name	Amneal Pharmaceuticals NY LLC
Pharmaceutical Class	Aluminum Complex [EPC], Organometallic Compounds [CS]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA215576
Listing Certified Through	2024-12-31

Package

NDC 69238-1656-05 (69238165605)

Pricing Information	N/A
NDC Package Code	69238-1656-5
Billing NDC	69238165605
Package	500 TABLET in 1 BOTTLE (69238-1656-5)
Marketing Start Date	2022-05-23
NDC Exclude Flag	N